---
title: "Cocrystal Pharma, Inc. (COCP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/COCP.US.md"
symbol: "COCP.US"
name: "Cocrystal Pharma, Inc."
industry: "制藥"
---

# Cocrystal Pharma, Inc. (COCP.US)

| Item | Detail |
|------|--------|
| Industry | 制藥 |
| Location | 美股市場 |
| Website | [www.cocrystalpharma.com](https://www.cocrystalpharma.com) |

## Company Profile

Cocrystal Pharma, Inc.是一家生物技術公司，專注于在美國發現和開發針對嚴重和/或慢性病毒疾病的抗病毒治療。該公司採用基于結構的技術來研發抗病毒藥物，包括流感病毒、冠狀病毒（如 SARS-CoV-2 和 MERS-CoV）、諾如病毒、呼吸道病毒感染以及丙型肝炎病毒（HCV）感染。公司正在開發 CC-42344，這是一種新型 PB2 抑制劑，目前處于 2a 期臨床試驗中，作為潛在的流感 A 型疫情和季節性流感的治療方案；以及吸入型 CC-42344，作為潛在的流感疫情和季節性流感感染的預防治療。公司還在開發 CDI-988，這是一種口服廣譜抗病毒藥物，目前處于 1 期臨床試驗中...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.40 | 115/257 | - | - | - |
| PB | 1.76 | 79/257 | 2.62 | 2.00 | 1.57 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-18T05:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 67% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.98 |
| Highest Target | 10.00 |
| Lowest Target | 6.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/COCP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/COCP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/COCP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.